Elizabeth Nabel
#26,864
Most Influential Person Now
American academic
Elizabeth Nabel's AcademicInfluence.com Rankings
Elizabeth Nabelphilosophy Degrees
Philosophy
#6627
World Rank
#9691
Historical Rank
Logic
#4407
World Rank
#5695
Historical Rank
Download Badge
Philosophy
Why Is Elizabeth Nabel Influential?
(Suggest an Edit or Addition)According to Wikipedia, Elizabeth Nabel is an American cardiologist and Executive Vice President of Strategy at ModeX Therapeutics and OPKO Health. Prior to this role, she served as President of Brigham Health and its Brigham and Women's Hospital, Professor of Medicine at Harvard Medical School, and Director of the NIH's National Heart, Lung, and Blood Institute.
Elizabeth Nabel's Published Works
Published Works
- Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. (1990) (1279)
- A tale of coronary artery disease and myocardial infarction. (2012) (874)
- Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. (1993) (873)
- Grand challenges in chronic non-communicable diseases (2007) (677)
- Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. (1988) (584)
- Site-specific gene expression in vivo by direct gene transfer into the arterial wall. (1990) (563)
- Circadian variation of transient myocardial ischemia in patients with coronary artery disease. (1987) (531)
- Heme oxygenase-1 protects against vascular constriction and proliferation (2001) (522)
- Gene therapy for vascular smooth muscle cell proliferation after arterial injury. (1994) (457)
- Recombinant gene expression in vivo within endothelial cells of the arterial wall. (1989) (432)
- Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. (1993) (401)
- Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury (2000) (394)
- Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo (1993) (388)
- Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. (1989) (374)
- Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. (1989) (371)
- Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts (2006) (356)
- Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability (2016) (341)
- Cardiovascular Pathology in Hutchinson-Gilford Progeria: Correlation With the Vascular Pathology of Aging (2010) (335)
- Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. (1990) (321)
- New models of collaboration in genome-wide association studies: the Genetic Association Information Network (2007) (313)
- A growth factor‐dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression (2002) (305)
- Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. (1988) (302)
- Expression of cyclin-dependent kinase inhibitors in vascular disease. (1998) (286)
- Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. (1992) (285)
- Gene transfer of Fas ligand induces tumor regression in vivo. (1997) (281)
- Genomics of cardiovascular disease. (2011) (278)
- Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts. (2011) (267)
- Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo. (1993) (264)
- Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. (2000) (256)
- Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. (1996) (253)
- Phenotype and course of Hutchinson-Gilford progeria syndrome. (2008) (252)
- Responses of coronary arteries of cardiac transplant patients to acetylcholine. (1988) (251)
- Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. (1996) (240)
- Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. (1992) (227)
- Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. (2000) (220)
- Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. (1990) (208)
- A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model (2008) (203)
- Cellular Senescence, Vascular Disease, and Aging: Part 2 of a 2-Part Review Clinical Vascular Disease in the Elderly (2011) (196)
- The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo (1995) (194)
- Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. (2000) (191)
- Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. (1992) (188)
- Gene therapy for cardiovascular disease. (1995) (185)
- Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells (1993) (185)
- Cellular Senescence, Vascular Disease, and Aging: Part 1 of a 2-Part Review (2011) (177)
- Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson–Gilford progeria syndrome (2006) (172)
- Heme Oxygenase-1 Deficiency Accelerates Formation of Arterial Thrombosis Through Oxidative Damage to the Endothelium, Which Is Rescued by Inhaled Carbon Monoxide (2007) (152)
- Immunization for Ebola virus infection (1998) (150)
- Angiotensin-converting enzyme 2--a new cardiac regulator. (2002) (135)
- A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. (1996) (135)
- Frequency of ST-segment depression produced by mental stress in stable angina pectoris from coronary artery disease. (1988) (127)
- Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. (2006) (124)
- Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B. (1991) (124)
- Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation (1994) (124)
- Adenovirus-Mediated Gene Transfer of VEGF121 Improves Lower-Extremity Endothelial Function and Flow Reserve (2001) (124)
- Mechanisms of Cardiovascular Disease in Accelerated Aging Syndromes (2007) (123)
- Variability of transient myocardial ischemia in ambulatory patients with coronary artery disease. (1988) (122)
- Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary. (2004) (119)
- Circadian rhythms and coronary artery disease. (1987) (118)
- Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis. (1992) (108)
- Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. (1996) (106)
- Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. (2002) (105)
- Features of the exercise test that reflect the activity of ischemic heart disease out of hospital. (1986) (105)
- Active transient myocardial ischemia during daily life in asymptomatic patients with positive exercise tests and coronary artery disease. (1986) (104)
- Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma. (1994) (101)
- Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group. (1989) (99)
- Effect of smoking on the activity of ischemic heart disease. (1989) (98)
- Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1. (2000) (95)
- Introduction of vascular smooth muscle cells expressing recombinant genes in vivo. (1991) (93)
- Immunotherapy for cancer by direct gene transfer into tumors. (1994) (90)
- A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. (1991) (89)
- The arginine methyltransferase PRMT2 binds RB and regulates E2F function. (2006) (85)
- Gene transfer into normal and atherosclerotic human blood vessels. (1998) (85)
- Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury. (1995) (84)
- Ebola Virus Glycoprotein Toxicity Is Mediated by a Dynamin-Dependent Protein-Trafficking Pathway (2005) (81)
- Protein Methyltransferase 2 Inhibits NF-κB Function and Promotes Apoptosis (2006) (81)
- Gene transfer and vascular disease. (1994) (80)
- Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 3: diagnosis and treatment of acute cardiac ischemia: gender issues. (2004) (78)
- Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. (1989) (76)
- Protecting Aggregate Genomic Data (2008) (74)
- Corrigendum: Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability (2017) (73)
- Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defect (2011) (73)
- Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. (1989) (72)
- Pharmacogenomics--ready for prime time? (2008) (72)
- Biology of the impaired endothelium. (1991) (72)
- CDKS and CKIS: Molecular targets for tissue remodelling (2002) (70)
- Disruption of Protein Arginine N-Methyltransferase 2 Regulates Leptin Signaling and Produces Leanness In Vivo Through Loss of STAT3 Methylation (2010) (68)
- Catheter-mediated pulmonary vascular gene transfer and expression. (1994) (68)
- Adenovirus-Mediated Transfer of the Herpes Simplex Virus Thymidine Kinase Gene Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation Following Balloon Angioplasty of the Rat Carotid Artery (1995) (67)
- Cardiovascular disease (2000) (66)
- Cell cycle and cell migration: new pieces to the puzzle. (2001) (65)
- Na+‐Ca2+ Exchange in Cultured Vascular Smooth Muscle Cells (1988) (62)
- Yang, Z.-Y. et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6, 886-889 (2000) (60)
- Transfection of human endothelial cells. (1997) (60)
- Selective elimination of recombinant genes in vivo with a suicide retroviral vector. (1991) (59)
- Coronary heart disease in women--an ounce of prevention. (2000) (57)
- p21CIP1 Controls Proliferating Cell Nuclear Antigen Level in Adult Cardiomyocytes (2003) (57)
- Bone marrow-derived immune cells regulate vascular disease through a p27(Kip1)-dependent mechanism. (2004) (57)
- Gene therapy for cardiovascular diseases (1999) (56)
- The Development of Human Gene Therapy (1999) (55)
- Combating chronic disease in developing countries (2009) (55)
- Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis. (2006) (54)
- Atherothrombosis and coronary artery disease (2005) (53)
- Relations Between Heart Rate, Ischemia, and Drug Therapy During Daily Life in Patients With Coronary Artery Disease (1990) (51)
- Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy. (2000) (51)
- Gene transfer into vascular cells. (1991) (51)
- Complex models for the study of gene function in cardiovascular biology. (1994) (49)
- Expression and function of a recombinant PDGF B gene in porcine arteries. (1995) (48)
- The cell cycle and cardiovascular diseases. (2003) (46)
- Cardiovascular Genomics, Personalized Medicine, and the National Heart, Lung, and Blood Institute: Part I: The Beginning of an Era (2008) (44)
- Ambulatory monitoring of the digitized electrocardiogram for detection and early warning of transient myocardial ischemia in angina pectoris. (1987) (42)
- Rationale and study design of the CardioGene Study: genomics of in-stent restenosis. (2004) (42)
- Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon. (1997) (40)
- Direct Gene Transfer for Treatment of Human Cancer (1995) (40)
- Neuropilin-1 Identifies Endothelial Precursors in Human and Murine Embryonic Stem Cells Before CD34 Expression (2009) (39)
- KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice. (2008) (38)
- Differential Temporal and Spatial Progerin Expression during Closure of the Ductus Arteriosus in Neonates (2011) (35)
- Responsiveness of atrial natriuretic factor to reduction in right atrial pressure in patients with chronic congestive heart failure. (1988) (33)
- Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells. (2004) (32)
- Introduction to clinical applications of stem cells at the National Institutes of Health: a meeting held on 24 May 2004 at the Clinical Center of the National Institutes of Health, Bethesda, Maryland, USA (2004) (31)
- Why data-sharing policies matter (2009) (31)
- In vivo gene delivery to the pulmonary circulation in rats: transgene distribution and vascular inflammatory response. (1997) (30)
- National Heart, Lung, and Blood Institute Perspective: Lung Progenitor and Stem Cells—Gaps in Knowledge and Future Opportunities (2009) (30)
- Heart Disease Prevention in Young Women: Sounding an Alarm. (2015) (29)
- Obesity on the brain (2005) (29)
- Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin. (1990) (28)
- Asymptomatic ischemia in patients with coronary artery disease. (1987) (27)
- Baroreflex regulation of regional blood flow in congestive heart failure. (1990) (26)
- GA‐binding protein regulates KIS gene expression, cell migration, and cell cycle progression (2008) (25)
- Prospects for genetic therapy of cardiovascular disease. (2000) (25)
- Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo. (2001) (24)
- The Protein Kinase KIS Impacts Gene Expression during Development and Fear Conditioning in Adult Mice (2012) (24)
- Relationship of cardiac chamber volume to baroreflex activity in normal humans. (1987) (22)
- CABG vs. stenting--clinical implications of the SYNTAX trial. (2009) (22)
- Gene therapy for vascular diseases. (1995) (22)
- Gene transfer and cardiovascular disease. (1991) (21)
- Stem cells combined with gene transfer for therapeutic vasculogenesis: magic bullets? (2002) (21)
- Requirements for Enhanced Transgene Expression by Untranslated Sequences from the Human Cytomegalovirus Immediate-Early Gene (1998) (20)
- Deficiency of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1 accelerates atherogenesis in apolipoprotein E-deficient mice. (2010) (19)
- In Vivo Gene Transfer: A Biological Tool (1997) (19)
- Pathophysiology of experimental renovascular hypertension. (1985) (17)
- A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention. (2011) (16)
- Balancing AMCs' missions and health care costs--mission impossible? (2013) (16)
- Direct gene transfer into the arterial wall. (1992) (16)
- Detection of pacing-induced myocardial ischemia by endocardial electrograms recorded during cardiac catheterization. (1988) (16)
- Direct Gene Transfer: Basic Studies and Human Therapies (1993) (16)
- Graft permeabilization facilitates gene therapy of transplant arteriosclerosis in a rabbit model. (1998) (15)
- Detection of Venous Thromboembolism by Proteomic Serum Biomarkers (2007) (15)
- chapter 9 – Gene Transfer Approaches for Cardiovascular Disease (2004) (15)
- Combination Gene Delivery of the Cell Cycle Inhibitor p27 with Thymidine Kinase Enhances Prodrug Cytotoxicity (1998) (14)
- Prmt2 Regulates the Lipopolysaccharide-Induced Responses in Lungs and Macrophages (2011) (13)
- NIH research on obesity and type 2 diabetes: providing the scientific evidence base for actions to improve health (2006) (12)
- A recommitment to sickle cell disease research. (2008) (12)
- Bone marrow – derived immune cells regulate vascular disease through a p 27 Kip 1-dependent mechanism (2004) (12)
- Gene transfer approaches to the regulation of vascular cell proliferation. (1996) (12)
- Recombinant Growth Factor Gene Expression in Vascular Cells in Vivo (1994) (11)
- Transition from placental to air breathing stimulates haem‐oxygenase‐1 expression without functional consequence for pulmonary vascular adaptation in pigs and mice (2005) (11)
- Conflict of interest--or conflict of priorities? (2006) (11)
- Direct transfer of a foreign MHC gene into human melanoma alters T cell receptor Vβ usage by tumor-infiltrating lymphocytes (1996) (11)
- Factors determining the activity of ischemic heart disease. (1986) (11)
- Characteristics and significance of ischemia detected by ambulatory electrocardiographic monitoring. (1987) (11)
- The Women's Health Initiative--a victory for women and their health. (2013) (10)
- Expression of a recombinant preproendothelin-1 gene in arteries stimulates vascular contractility. (1997) (10)
- Genetic therapy. (1996) (9)
- On Averaging Power for Genetic Association and Linkage Studies (2005) (8)
- Essentials of Restenosis (2007) (8)
- Delivering genes to the heart—right where it counts! (1999) (8)
- New approaches to pulmonary hypertension: will therapies in mice work in humans? (2000) (7)
- Time course analysis of gene expression identifies multiple genes with differential expression in patients with in-stent restenosis (2011) (7)
- Development and validation of ambulatory monitoring to characterize ischemic heart disease out of hospital. (1986) (7)
- Meeting report: NHLBI symposium on phenotyping: mouse cardiovascular function and development. (2003) (7)
- Molecular genetic interventions for cancer. (1994) (6)
- The cardiovascular programs of the National Heart, Lung, and Blood Institute: from vision to action to impact. (2009) (6)
- Linking biomedical research to health care. (2009) (6)
- Duckers, H.R. Heme oxygenase-1 protects against vascular constriction and proliferation. Nature Med. 7, 692-698 (2001) (6)
- Promoter Targets Gene Expression to Vascular Smooth Muscle Cells In Vitro and In Vivo (2000) (5)
- Genomics of in-stent restenosis: early insights into a complex disease. (2005) (5)
- Notes from the Director, National Heart, Lung, and Blood Institute: NHLBI core values and shaping the 2007 budget. (2007) (5)
- Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of interferon-beta (IFN-β) (1997) (5)
- The Women's Health Initiative (2006) (5)
- Liposome Mediated Gene Transfer into Vascular Cells (1993) (5)
- The physician-scientist: a value proposition. (2008) (5)
- Shaping the future of research: the NHLBI strategic plan. (2007) (5)
- Cardiovascular insights from a premature aging syndrome: a translational story. (2012) (5)
- On Board with the Cures Acceleration Network (2010) (4)
- Notes from the director of the National Heart, Lung, and Blood Institute: shaping the future of research: the NHLBI strategic plan. (2007) (4)
- Morphological analysis of balloon mitral vulvuloplasty: Intra-operative results (1990) (4)
- Principles of Cardiovascular Molecular Biology and Genetics (2012) (4)
- [Direct gene transfer in the rat kidney in vivo]. (1997) (4)
- Notes from the NHLBI director: fostering the independence of new investigators. (2005) (3)
- Cell cycle signaling and cardiovascular disease. (2002) (3)
- A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model (Proceedings of the National Academy of Sciences of the United States of America (2008) 105, (15902-15907) DOI: 10.1073/pnas.0807840105) (2009) (3)
- Na +-Ca 2 + Exchange in Cultured Vascular Smooth Muscle Cells (2005) (3)
- National Heart, Lung, and Blood Institute: transitions. (2009) (3)
- Data and safety monitoring of rosiglitazone trials (2007) (3)
- Direct Gene Transfer and Catheter Based Gene Delivery Systems: Applications to Cardiovascular Diseases and Malignancy (1994) (3)
- Shaping the future of research: the NHLBI strategic plan. (2007) (3)
- Fostering the independence of new investigators. (2005) (3)
- Notes from the Director National Heart, Lung, and Blood Institute: fostering the independence of new investigators. (2005) (3)
- What can cardiovascular gene transfer learn from genomics: and vice versa? (2002) (2)
- A vision for the future: opportunities and challenges: notes from the director of the National Heart, Lung, and Blood Institute. (2005) (2)
- Abstract 16392: Oxido-Reductive Regulation of Human Vascular Remodeling by the Orphan Receptor Tyrosine Kinase Ros1 (2014) (2)
- A vision for the future: opportunities and challenges. (2005) (2)
- Treating COPD. (2007) (2)
- Response to: "Rescuing the NIH before it is too late". (2006) (2)
- Message from the Director of the National, Heart, Lung, and Blood Institute, National Institutes of Health (2008) (2)
- Notes from the NHLBI Director: a vision for the future: opportunities and challenges. (2005) (2)
- Abstract 18618: Endothelial to Mesenchymal Transition Contributes to Atherosclerotic Plaque Formation and Correlates With Plaque Instability (2016) (2)
- Inhcer of β-Interferon (1997) (1)
- Gene therapy for coronary artery disease: The University of Michigan Program. (1998) (1)
- The golden egg--making good on discovery and translation. (2002) (1)
- Activity of transient myocardial ischemia out of hospital in coronary artery disease and implications for management. (1985) (1)
- Circulation Research: A New Era (1998) (1)
- Notes from the NHLBI director: shaping the future of research--the NHLBI strategic plan. (2007) (1)
- Notes from the NHLBI director: transitions. (2009) (1)
- Abstract 3689: Genome Wide Association Study of In-stent Restenosis Identifies Multiple Candidate Susceptibility Loci (2006) (1)
- Notes from the Director, National Heart, Lung, and Blood Institute: NHLBI core values and shaping the 2007 budget. (2007) (1)
- Acceptance of the 2014 Association of American Physicians George M. Kober Medal. Giving back. (2014) (1)
- Direct transfer of transforming growth factor j81 gene into arteries stimulates fibrocellular hyperplasia (gene transfer/gene expression/extraceliular matrix/ceilular proliferation) (2005) (1)
- Testes and Testicular Disorders (2020) (0)
- CORONARY VASOSPASM Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test (2005) (0)
- Genetic Models of Vascular Disease (1995) (0)
- 59 Mouse models for the study of pai function in tissue injury and repair (1997) (0)
- Patent Number : 45 ) Date of Patent : 5 , 328 , 470 Jul . 12 , 1994 pression in Rabbit Endothelial Cells Transduced by Retroviral Vectors (2017) (0)
- Directions: Report of the National Heart, Lung and Blood Institute Workshop: October 2 Women's Ischemic Syndrome Evaluation : Current Status and Future Research (2012) (0)
- Correction: Differential Temporal and Spatial Progerin Expression during Closure of the Ductus Arteriosus in Neonates (2011) (0)
- Passing the baton (2014) (0)
- Longitudinal stretch and pressure facilitate gene transfer into rabbit aortic media without endothelial denudation (1996) (0)
- SPATIAL AND TEMPORAL EXPRESSION PATTERN OF KIS DURING MOUSE DEVELOPMENT (2004) (0)
- Protein Methyltransferase 2 Inhibits NF- (cid:2) B Function and Promotes Apoptosis† (2006) (0)
- Deletion of KIS accelerates intimal hyperplasia in response to vascular injury and enhances migratory activity of VSMC (2006) (0)
- Gene Therapy for Atherosclerosis (2000) (0)
- Chapter 32. Perspectives on Human Gene Therapy (1991) (0)
- The Commonwealth of Massachusetts Health Policy Commission Two Boylston Street Boston, MA 02116 (2014) (0)
- Lipid Oil red O Macrophages CD 68 Hyaluronan Receptor CD 44 Hyaluronan HABP HG 001-RCA (2010) (0)
- Methods for liposome-mediated gene transfer to tumor cells in vivo. (1997) (0)
- Viral Vector-Based Vascular Gene Delivery: Basic Studies and Therapeutic Applications (1997) (0)
- Cell Cycle Approaches to the Treatment of In-Stent Restenosis (2007) (0)
- The ambitions and goals of the National Heart, Lung, and Blood Institute at The National Institute of Health. (2009) (0)
- Pushing the boundaries of science in a changing landscape: The ambitions and goats of the National Heart, Lung, and Blood Institute at The National Institute of Health (2009) (0)
- AHA Journals at the Forefront of Cardiology (1998) (0)
- The renin-angiotensin axis during acute myocardial infarction treated with combined intravenous tissue plasminogen activator and captopril (1990) (0)
- A vision for the future: notes from the NHLBI director. (2005) (0)
- Abstract 12760: Identification of a Novel Susceptibility Locus on Chromosome 12 With the First Genome-Wide Association Study on Coronary Restenosis (2011) (0)
- Erratum: How to become a cardiovascular investigator (Journal of the American College of Cardiology (October 4, 2005) SUPPL. A)) (2005) (0)
- Methods for liposome-mediated gene transfer to the arterial wall. (1997) (0)
- Smoking Aggravates Myocardial Ischemia During Daily Life (1988) (0)
- Ambulatory Patients With Coronary Artery Disease (2005) (0)
- [Gene transfer of interferon beta inhibits vascular smooth muscle cell proliferation in vitro and in animal model of arterial injury]. (1997) (0)
- CLINICAL PROTEOMICS IN VENOUS THROMBOEMBOLISM: APPLICATION OF A NOVEL MALDI-TOF MASS SPECTROMETRIC PROTEOMIC METHOD FOR SERUM BIOMARKER ASSESSMENT (2004) (0)
- Analysis of recombinant gene expression and function in arteries following direct gene transfer (1994) (0)
- Relations Between HeartRate,Ischemia, and DrugTherapy DuringDailyLifeinPatients WithCoronary Artery Disease (1991) (0)
- 2.W12.3 CKIs and control of vascular smooth muscle cell cycle (1997) (0)
- Vectors for Gene Therapy (1999) (0)
- Risk Factors for Coronary Artery Disease (2005) (0)
- Abstract 720: Neuropilin 1 Identifies Endothelial Precursors in Murine and Human Embryonic Stem Cells Prior to CD34 Expression (2007) (0)
- ETS-1 CONTROLS HKIS GENE EXPRESSION—A REGULATOR OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION (2004) (0)
- Obama's research funding boost for medicine. (2009) (0)
- Reflections on a Life in Biomedicine: Leading Change (2013) (0)
- Dilation ofnormalandconstriction of atherosclerotic coronaryarteries caused bythecold pressortest (1988) (0)
- Vasoconstrictor-mediated ionic events associated with sustained contractile responses in cultured vascular smooth muscle cells (1987) (0)
- Gene Transfer and Vascular Remodeling (1997) (0)
- Influences the Vasomotor Remoonse of Epicardial Coronary Arteries to Exercise (1989) (0)
- Safety a n d Toxicity o f Catheter G e n e Delivery to the P u l m o n a r y Vasculature in a Patient with Metastatic (2009) (0)
- Advancing Clinical Care and Medical Understanding in a Resource-Limited Setting: Lessons From the Aro Village Project in the Wake of the Affordable Care Act (2017) (0)
- Delivery Systems for Gene Therapy (2008) (0)
- Gene therapy for transplant arteriosclerosis (1997) (0)
- Date of Patent : ( 54 ) USE OF ONION EXTRACTS TO PREVENT AND TREAT ACUTE AND CHRONIC CARDAC AND VASCULAR COMPLICATIONS AND THEIR SEQUELAE (2017) (0)
- REPORTS ON THERAPY A Randomized Placebo-Controlled Trial of Combined Early Intravenous Captopril and Recombinant Tissue-Type Plasminogen Activator Therapy in Acute Myocardial Infarction (2016) (0)
- THE CELL CYCLE INHIBITOR P27KIP1 MODULATES THE CONTRIBUTION OF BONE MARROW DERIVED CELLS TO THE NEOINTIMA DURING ARTERIAL WOUND REPAIR (2004) (0)
- Kamed and Invited Lectures (2004) (0)
- Exercise (2018) (0)
- REGULATION OF CELL CYCLE PROGRESSION IN VASCULAR SMOOTH MUSCLE CELLS : BREAKING THE CYCLE (1999) (0)
- Delivery Systems for Gene Therapy (2000) (0)
- Comprar Essentials of Restenosis · For the Interventional Cardiologist | Duckers, Henricus J. | 9781588294913 | Springer (2007) (0)
- Interview with Dr. Elizabeth G. Nabel, Director, National Heart, Lung, and Blood Institute. Interview by Stuart F. Quan. (2005) (0)
- n the Development High Dose Transdermal (1989) (0)
- For the gene therapy plasmids usable (1994) (0)
- Gene Therapy: Vector Design and Current Challenges (1997) (0)
- Proteomics and Restenosis (2007) (0)
- Notes from the NHLBI Director: National Heart, Lung, and Blood Institute core values and shaping the 2007 budget. (2007) (0)
This paper list is powered by the following services:
Other Resources About Elizabeth Nabel
What Schools Are Affiliated With Elizabeth Nabel?
Elizabeth Nabel is affiliated with the following schools: